Analystreport

Regeneron Pharmaceuticals Inc (NASDAQ: REGN) was downgraded by analysts at BTIG Research from a "buy" rating to a "neutral" rating.

Regeneron Pharmaceuticals, Inc.  (REGN) 
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com